Concept Life Sciences becomes a part of Spectris

| By | Drug Development, Laboratories, R&D
0
212

Concept Life Sciences, the integrated drug discovery, development and analytical services and environmental consultancy company based in UK, today announced the completion of its acquisition by Spectris plc, the productivity-enhancing instrumentation and controls company.

Concept represents a new, high-growth area for Spectris, and will become a separate operating company within its Materials Analysis segment where it has strong synergies with the activities of Malvern Panalytical. As a result of the acquisition, Concept’s customers will benefit from access to Malvern Panalytical’s expertise in molecular testing and analysis. In the medium term, Concept’s in-depth scientific offering, customer knowledge and application insights, combined with Malvern Panalytical’s deep domain knowledge and broad reach, will enable increased innovation across the combined group.

Concept has achieved significant growth over the period 2015-2017. The recent acquisition of Aquila Biomedical, an immunotherapy business, significantly added to the Company’s reach in integrated drug discovery and development services. Additionally, Concept expanded its capacity in August 2017 by opening new laboratories at the international science hub Alderley Park, UK.

Being part of a large, global organisation will help Concept Life Science’s growth with international customers and expansion into new markets, both organically and via potential acquisitions.

Michael Fort, Executive Chairman, Concept Life Sciences, commented: “Concept was positioning for a sale in late 2018/early 2019, and we are therefore delighted that our success has been recognised by Spectris, leading to an earlier than planned acquisition. The global footprint of Spectris along with their expertise in complementary activities and experienced management team offers the infrastructure to support Concept’s ambitions for international growth. We are very excited to begin working together.”